Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Lipid-based Nanoparticles As Pharmaceutical Drug Carriers: From Concepts To Clinic.
A. Puri, Kristin S. Loomis, B. Smith, J. Lee, Amichai Yavlovich, E. Heldman, R. Blumenthal
Published 2009 · Chemistry, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
In recent years, various nanotechnology platforms in the area of medical biology, including both diagnostics and therapy, have gained remarkable attention. Moreover, research and development of engineered multifunctional nanoparticles as pharmaceutical drug carriers have spurred exponential growth in applications to medicine in the last decade. Design principles of these nanoparticles, including nanoemulsions, dendrimers, nano-gold, liposomes, drug-carrier conjugates, antibody-drug complexes, and magnetic nanoparticles, are primarily based on unique assemblies of synthetic, natural, or biological components, including but not limited to synthetic polymers, metal ions, oils, and lipids as their building blocks. However, the potential success of these particles in the clinic relies on consideration of important parameters such as nanoparticle fabrication strategies, their physical properties, drug loading efficiencies, drug release potential, and, most importantly, minimum toxicity of the carrier itself. Among these, lipid-based nanoparticles bear the advantage of being the least toxic for in vivo applications, and significant progress has been made in the area of DNA/RNA and drug delivery using lipid-based nanoassemblies. In this review, we will primarily focus on the recent advances and updates on lipid-based nanoparticles for their projected applications in drug delivery. We begin with a review of current activities in the field of liposomes (the so-called honorary nanoparticles), and challenging issues of targeting and triggering will be discussed in detail. We will further describe nanoparticles derived from a novel class of amphipathic lipids called bolaamphiphiles with unique lipid assembly features that have been recently examined as drug/DNA delivery vehicles. Finally, an overview of an emerging novel class of particles (based on lipid components other than phospholipids), solid lipid nanoparticles and nanostructured lipid carriers will be presented. We conclude with a few examples of clinically successful formulations of currently available lipid-based nanoparticles.
This paper references
Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.
W. Cheng (2008)
Solid Lipid Nanoparticles as Delivery Systems for Bromocriptine
E. Esposito (2007)
Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects
S. Garde (2007)
HER‐2‐Targeted Nanoparticle–Affibody Bioconjugates for Cancer Therapy
F. Alexis (2008)
Fluid and air-stable lipopolymer membranes for biosensor applications.
Fernando Albertorio (2005)
HER‐2‐Targeted Antisense Oligonucleotide Results in Sensitization of Head and Neck Cancer Cells to Chemotherapeutic Agents
A. Rait (2003)
Binding of antigen-bearing fluorescent liposomes to the murine myeloma tumor MOPC 315.
L. Leserman (1979)
Improved Therapeutic Responses in a Xenograft Model of Human B Lymphoma (Namalwa) for Liposomal Vincristine versus Liposomal Doxorubicin Targeted via Anti-CD19 IgG2a or Fab′ Fragments
P. Sapra (2004)
Discovery and Development of Folic‐Acid‐Based Receptor Targeting for Imaging and Therapy of Cancer and Inflammatory Diseases
P. Low (2008)
Use of the post-insertion method for the formation of ligand-coupled liposomes.
T. Allen (2002)
Archaeosome Vaccine Adjuvants Induce Strong Humoral, Cell-Mediated, and Memory Responses: Comparison to Conventional Liposomes and Alum
L. Krishnan (2000)
V. Torchilin (2000)
Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid.
X. Q. Pan (2002)
The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors.
D. Needham (2001)
Homing of liposomes to target cells.
G. Gregoriadis (1975)
Engineered lipids that cross-link the inner and outer leaflets of lipid bilayers.
M. Halter (2004)
U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis.
A. Meyerhoff (1999)
E. Evans (1976)
Biodegradable luminescent porous silicon nanoparticles for in vivo applications.
J. Park (2009)
Sterically stabilized anti‐idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B‐cell lymphoma model
Y. Tseng (1999)
A biosensor that uses ion-channel switches
B. Cornell (1997)
Tetraether bolaform amphiphiles as models of archaebacterial membrane lipids: Raman spectroscopy, phosphorus-31 NMR, x-ray scattering, and electron microscopy
D. Thompson (1992)
Doxorubicin-loaded Fab' fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice.
F. Pastorino (2003)
Reversal activity of nanostructured lipid carriers loading cytotoxic drug in multi-drug resistant cancer cells.
Xing-guo Zhang (2008)
The use of solid lipid nanoparticles to target a lipophilic molecule to the liver after intravenous administration to mice.
W. Lu (2008)
Synthesis and characterization of head group modified 1,3 diacetylenic phospholipids
A Singh (1989)
A phase 1 study of OSI-211 given as an intravenous infusion days 1, 2, and 3 every three weeks in patients with solid cancers
K. Gelmon (2004)
Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier.
M. Schubert (2005)
Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.
D. Papahadjopoulos (1991)
Design of liposomes containing photopolymerizable phospholipids for triggered release of contents
Amichai Yavlovich (2009)
Structure of polymerizable lipid bilayers. I--1,2-bis(10,12-tricosadiynoyl)-sn-glycero-3-phosphocholine, a tubule-forming phosphatidylcholine.
D. Rhodes (1988)
Stimuli-responsive polymersomes for programmed drug delivery.
F. Meng (2009)
Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts.
L. Xu (1999)
Targeting of parasite-specific immunoliposome-encapsulated doxorubicin in the treatment of experimental visceral leishmaniasis.
S. Mukherjee (2004)
Can ether liposomes be used for oral vaccines
EL Chang (1994)
Synthesis of carbamyl and ether analogs of phosphatidylcholines
K. Agarwal (1984)
Structural investigations on lipid nanoparticles containing high amounts of lecithin.
M. Schubert (2006)
Preparation of solid lipid nanoparticles using a membrane contactor.
C. Charcosset (2005)
Targeting of epidermal growth factor receptor (EGFR)-expressing tumor cells with sterically stabilized affibody liposomes (SAL).
Julia Beuttler (2009)
Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles.
H. L. Wong (2007)
Hyperthermia mediated liposomal drug delivery
A. M. Ponce (2006)
Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo.
C. Mamot (2005)
The lipids of archaebacteria.
M. De Rosa (1988)
Tumor-specific antibody-mediated targeted delivery of Doxil reduces the manifestation of auricular erythema side effect in mice.
T. Elbayoumi (2008)
Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice.
O. Ishida (1999)
Drug delivery systems using immobilized intact liposomes: a comparative and critical review.
Heïdi Brochu (2004)
Modification of phospholipid structure results in greater stability if liposomes in serum.
C. Gupta (1981)
Poly(ethylene glycol)--lipid conjugates regulate the calcium-induced fusion of liposomes composed of phosphatidylethanolamine and phosphatidylserine.
J. W. Holland (1996)
Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors
H. Shmeeda (2006)
Cytotoxic tumor targeting with scFv antibody-modified liposomes.
C. Marty (2005)
Lipid Nanotubes: Formation, Templating Nanostructures and Drug Nanocarriers
Yong Zhou (2008)
Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns
T. Göppert (2005)
Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel.
M. Immordino (2003)
Wavelength-programmed solute release from photosensitive liposomes.
R. Bisby (2000)
Chemical approaches to triggerable lipid vesicles for drug and gene delivery.
Xin Guo (2003)
Transitions of organized assemblies in mixed systems of cationic bolaamphiphile and anionic conventional surfactants.
Ting Lu (2006)
Application of NMR spectroscopy to the characterization of PEG-stabilized lipid nanoparticles.
M. Garcia-Fuentes (2004)
Solid lipid nanoparticles as a drug delivery system for peptides and proteins.
A. Almeida (2007)
Targeting Stealth liposomes in a murine model of human small cell lung cancer.
J. Moreira (2001)
A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene
W. Yu (2004)
Liposomes as delivery agents for medical imaging.
V. Torchilin (1996)
Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
E. Murphy (2008)
Transfersomes: self-optimizing carriers for bioactives.
K. Rai (2008)
Selective Construction of Supramolecular Nanotube Hosts with Cationic Inner Surfaces
N. Kameta (2005)
Design and synthesis of asymmetric acyclic phospholipid bolaamphiphiles.
Toshitsugu Kai (2005)
Carbamyl analogs of phosphatidylcholines. Synthesis, interaction with phospholipases and permeability behavior of their liposomes.
C. Gupta (1981)
Stability and proton-permeability of liposomes composed of archaeal tetraether lipids.
M. Elferink (1994)
Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes.
L. Xu (2002)
Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems.
Patel Gb (1999)
J. Maynard (2000)
In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.
D. E. Lopes de Menezes (1998)
Diffusion of univalent ions across the lamellae of swollen phospholipids.
A. Bangham (1965)
Influence of the Formulation for Solid Lipid Nanoparticles Prepared with a Membrane Contactor
Assma Ahmed El-Harati (2006)
Elastic liposomes for topical and transdermal drug delivery.
H. Benson (2009)
Nanoparticles in Medicine: Therapeutic Applications and Developments
L. Zhang (2008)
Spontaneous vesicle formation in aqueous mixtures of single-tailed surfactants.
E. Kaler (1989)
FORMATION OF STABLE BILAYER ASSEMBLIES IN WATER FROM SINGLE-CHAIN AMPHIPHILES. RELATIONSHIP BETWEEN THE AMPHIPHILE STRUCTURE AND THE AGGREGATE MORPHOLOGY
T. Kunitake (1981)
Design of liposomes for enhanced local release of drugs by hyperthermia.
M. Yatvin (1978)
Thermoresponsive and biodegradable linear-dendritic nanoparticles for targeted and sustained release of a pro-apoptotic drug.
Thomas C. Stover (2008)
Activity of amphotericin B cholesterol dispersion (Amphocil) in experimental visceral leishmaniasis.
J. Berman (1992)
Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery.
Emily Gullotti (2009)
Nanoparticle therapeutics: an emerging treatment modality for cancer
M. Davis (2008)
Novel cationic vesicle platform derived from vernonia oil for efficient delivery of DNA through plant cuticle membranes.
Z. Wiesman (2007)
Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer.
Olga Garbuzenko (2005)
Recent Advances in Tumor-Targeting Anticancer Drug Conjugates
Stanislav Jaracz (2005)
Nanomedicines for overcoming biological barriers.
M. Alonso (2004)
Phase I study results of nanomolecular liposomal annamycin in refractory ALL.
R. Shepard (2009)
HER2-specific affibody-conjugated thermosensitive liposomes (Affisomes) for improved delivery of anticancer agents.
A. Puri (2008)
Unusual thermal stability of liposomes made from bipolar tetraether lipids.
E. Chang (1994)
Nanostructured Lipid Carriers-Containing Anticancer Compounds: Preparation, Characterization, and Cytotoxicity Studies
M. Bondì (2007)
Anti-CD19-Targeted Liposomal Doxorubicin Improves the Therapeutic Efficacy in Murine B-Cell Lymphoma and Ameliorates the Toxicity of Liposomes with Varying Drug Release Rates
T. Allen (2005)
Lipid nanoparticles for parenteral delivery of actives.
Medha D. Joshi (2009)
Preparation and Characterization of Solid Lipid Nanoparticles Containing Cloricromene
M. Bondì (2003)
Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer.
G. Batist (2001)
Fusion and endocytosis of anionic liposomes with Ehrlich ascitic carcinoma cells
Yu. A. Goryacheva (2006)
Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN).
T. Göppert (2005)
Formulation of photocleavable liposomes and the mechanism of their content release.
Binita Chandra (2006)
36-Membered Macrocyclic Diether Lipid is Advantageous for Archaea to Thrive under the Extreme Thermal Environments
K. Arakawa (2001)
Liposomes. Opportunities in drug delivery.
T. Allen (1997)
Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours.
A. Gabizon (1997)
Effects of the size and fluidity of liposomes on their accumulation in tumors: A presumption of their interaction with tumors
Kazuko Uchiyama (1995)
The use of pH-triggered leaky heterogeneities on rigid lipid bilayers to improve intracellular trafficking and therapeutic potential of targeted liposomal immunochemotherapy.
S. Karve (2009)
Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: results of therapy and correlates of response.
A. Levine (2004)
Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes.
Avi Schroeder (2009)
Liposomes with Triggered Content Release for Cancer Therapy
A. Alaouie (2008)
Expression and purification of two anti-CD19 single chain Fv fragments for targeting of liposomes to CD19-expressing cells.
W. Cheng (2007)
Immunoliposomes Directed Toward VCAM-1 Interact Specifically with Activated Endothelial Cells—A Potential Tool for Specific Drug Delivery
M. Voinea (2005)
Ultrasound mediated delivery of drugs and genes to solid tumors.
V. Frenkel (2008)
Nanostructured Lipid Carriers : A Novel Generation of Solid Lipid Drug Carriers
M. Radtke (2005)
Stability of liposomes in circulation is markedly enhanced by structural modification of their phospholipid component
A. Bali (1983)
Cytotoxicity of folate-Pseudomonas exotoxin conjugates toward tumor cells. Contribution of translocation domain.
C. P. Leamon (1993)
Membrane viscoplastic flow.
E. Evans (1976)
Polymerized liposomes : From biophysics to applications. Part II
D. Lasic (2000)
Self-assembly of a virus-mimicking nanostructure system for efficient tumor-targeted gene delivery.
L. Xu (2002)
Potential of solid lipid nanoparticles in brain targeting.
I. P. Kaur (2008)
D. Fenske (2008)
Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial.
F. Meunier (1991)
The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma.
Zhenghong Xu (2009)
Nanostructured lipid carriers (NLC) in cosmetic dermal products.
R. Mueller (2007)
Synthesis and biological activity of anticancer ether lipids that are specifically released by phospholipase A2 in tumor tissue.
T. Andresen (2005)
ABSENCE OF HISTOLOGIC RETINAL TOXICITY OF INTRAVITREAL NANOGOLD IN A RABBIT MODEL
S. Bakri (2008)
Enhanced transfection efficiency of a systemically delivered tumor-targeting immunolipoplex by inclusion of a pH-sensitive histidylated oligolysine peptide.
Wei Yu (2004)
Solid lipid nanoparticles for parenteral drug delivery.
S. Wissing (2004)
Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs.
T. Andresen (2004)
Nanomedicine—Challenge and Perspectives
K. Riehemann (2009)
Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies
T. Elbayoumi (2006)
Micellar Nanocarriers: Pharmaceutical Perspectives
V. Torchilin (2006)
Ligand-targeted therapeutics in anticancer therapy
T. Allen (2002)
A Folate Receptor–Targeted Lipid Nanoparticle Formulation for a Lipophilic Paclitaxel Prodrug
P. J. Stevens (2004)
A Novel Phase Inversion-Based Process for the Preparation of Lipid Nanocarriers
B. Heurtault (2004)
Phase behavior of fluorocarbon and hydrocarbon double-chain hydroxylated and galactosylated amphiphiles and bolaamphiphiles. Long-term shelf-stability of their liposomes.
L. Clary (1999)
Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids.
V. Jenning (2000)
Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia
D. Thomas (2006)
Effects of humanization and gene shuffling on immunogenicity and antigen binding of anti‐tag‐72 single‐chain Fvs
G. Pavlinkova (2001)
Routes to Functional Vesicle Membranes without Proteins
J. Fuhrhop (1984)
A New Analytical Device Based on Gated Ion Channels: A Peptide-Channel Biosensor
C. Weiss-Wichert (1997)
A phase II, open label, monotherapy study of liposomal doxorubicin in patients with metastatic malignant melanoma
M. Smylie (2006)
Trends and developments in liposome drug delivery systems.
T. Lian (2001)
DOXIL (pegylated liposomal doxorubicin): clinical update. Abstracts of Papers of the American Chemical Society 1996;211:34
FJ Martin (1996)
Physicochemical and biological characterization of ceramide-containing liposomes: paving the way to ceramide therapeutic application.
Elena Khazanov (2008)
A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model.
D. Needham (2000)
Lipid-based colloidal carriers for peptide and protein delivery – liposomes versus lipid nanoparticles
S. Martins (2007)
Liposome technology and the development of Myocet™ (liposomal doxorubicin citrate)
C. Swenson (2001)
The use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemia
A. Fassas (2005)
Solid lipid nano-particles--a novel carrier system for cosmetics and pharmaceutics
RH Muller (1997)
Exploiting vegetable oils for the delivery of hydrophilic drugs
S. Grinberg (2010)
Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
Todd O. Pangburn (2009)
Ligand-targeted liposomal anticancer drugs.
P. Sapra (2003)
In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
A. Gabizon (2003)
Synthesis of a labeled RGD-lipid, its incorporation into liposomal nanoparticles, and their trafficking in cultured endothelial cells.
Sonya Cressman (2009)
The influence of solid lipid nanoparticles on skin hydration and viscoelasticity--in vivo study.
S. Wissing (2003)
Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging.
D. Tomalia (2007)
Supramolecularassemblies for the active drug targeting to the brain
A. Béduneau (2009)
Ligand-targeted liposomes for cancer treatment.
P. Sapra (2005)
Triggered activation and release of liposomal prodrugs and drugs in cancer tissue by secretory phospholipase A2.
T. Andresen (2005)
Novel cationic amphiphilic derivatives from vernonia oil: synthesis and self-aggregation into bilayer vesicles, nanoparticles, and DNA complexants.
S. Grinberg (2005)
Self-assembling micelle-like nanoparticles based on phospholipid-polyethyleneimine conjugates for systemic gene delivery.
Y. Ko (2009)
Non-Covalent Conjugation of Nanoparticles to Antibodies via Electrostatic Interactions—A Computational Model
I. Sidorov (2007)
Binding of antibodies in liposomes to extracellular matrix antigens
V. Torchilin (1985)
HELICAL SUPERSTRUCTURES ARE FORMED FROM CHIRAL AMMONIUM BILAYERS
N. Nakashima (1984)
Future directions of liposome- and immunoliposome-based cancer therapeutics.
J. Park (2004)
Total Synthesis of Archaeal 36-Membered Macrocyclic Diether Lipid.
T. Eguchi (1997)
In vitro efficacy of a sterically stabilized immunoliposomes targeted to membrane type 1 matrix metalloproteinase (MT1-MMP).
K. Atobe (2007)
Antitumor Effect of Paclitaxel-Loaded PEGylated Immunoliposomes Against Human Breast Cancer Cells
T. Yang (2007)
Aggregation and hemi-fusion of anionic vesicles induced by the antimicrobial peptide cryptdin-4.
Jason E. Cummings (2007)
Recent advances and patents on solid lipid nanoparticles.
K. Sawant (2008)
Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
J. Park (2002)
Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy.
P. Pradhan (2010)
Fast laser-induced solute release from liposomes sensitized with photochromic lipid: effects of temperature, lipid host, and sensitizer concentration.
R. Bisby (1999)
Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic.
X. Xiong (2005)
Isolation of endothelial cell-specific human antibodies from a novel fully synthetic scFv library.
T. Völkel (2004)
Chemical relaxation and equilibrium studies of association in aqueous solutions of bolaform detergents. 3. Docosane-1,22-bis(trimethylammonium bromide)
R. Zana (1980)
Receptor-mediated uptake of asialoganglioside liposomes: sub-cellular distribution of the liposomal marker in isolated liver cell types.
P. Dasgupta (1985)
Nanotechnology in Medical Imaging: Probe Design and Applications
D. Cormode (2009)
Polymerized phosphatidyl choline vesicles. Stabilized and controllable time-release carriers.
S. Regen (1981)
Formation of Stable Monolayer Membranes and Related Structures in Dilute Aqueous Solution from Two-Headed Ammonium Amphiphiles
Y. Okahata (1979)
Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery.
K. Pirollo (2006)
Monolayer lipid membrane-forming dissymmetrical bolaamphiphiles derived from alginate oligosaccharides.
M. Roussel (2006)
Fast solute release from photosensitive liposomes: an alternative to ‘caged’ reagents for use in biological systems
C. Morgan (1995)
STABILITY OF LIPOSOMES PREPARED FROM THE TOTAL POLAR LIPIDS OF METHANOSARCINA MAZE1 IS AFFECTED BY THE SPECIFIC SALT FORM OF THE LIPIDS
G. B. Patel (1999)
Evaluation of percutaneous absorption of the repellent diethyltoluamide and the sunscreen ethylhexyl p‐methoxycinnamate‐loaded solid lipid nanoparticles: an in‐vitro study
C. Puglia (2009)
Construction of nanogold hollow balls with dendritic surface as immobilized affinity support for protein adsorption.
J. Liao (2007)
Folate-targeted therapeutic and imaging agents for cancer.
P. Low (2009)
Dibucaine effects on structural and elastic properties of lipid bilayers.
G. S. Lorite (2009)
Biofunctionalized targeted nanoparticles for therapeutic applications.
A. Wang (2008)
Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin
T. Boulikas (2009)
A phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphoma
P. Mitchell (2008)
R. Jahn (2003)
Current dendrimer applications in cancer diagnosis and therapy.
I. Majoros (2008)
VIP receptors as molecular targets of breast cancer: implications for targeted imaging and drug delivery.
S. Dagar (2001)
Preclinical Manufacture of an Anti‐HER2 scFv‐PEG‐DSPE, Liposome‐Inserting Conjugate. 1. Gram‐Scale Production and Purification
David F. Nellis (2005)
Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats.
A. Fundaró (2000)
Transferrin‐conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain
Yashwant Gupta (2007)
Antibody-modified liposomes for cancer chemotherapy.
V. Torchilin (2008)
Liposome fluidity alters interactions between the ganglioside GM1 and cholera toxin B subunit.
James Terrell (2008)
Phase II study of liposomal cisplatin (Lipoplatin) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer.
N. Mylonakis (2010)
Drug Delivery Systems: Entering the Mainstream
T. Allen (2004)
Cadmium-containing nanoparticles: perspectives on pharmacology and toxicology of quantum dots.
B. Rzigalinski (2009)
The depth of porphyrin in a membrane and the membrane's physical properties affect the photosensitizing efficiency.
A. Lavi (2002)
Controllable biomolecule release from self-assembled organic nanotubes with asymmetric surfaces: pH and temperature dependence.
N. Kameta (2008)
Bolaamphiphiles and Monolayer Lipid Membranes Made from 1,6,19,24-Tetraoxa-3,21-cyclohexatriacontadiene-2,5,20,23-tetrone
Juergen-Hinrich Fuhrhop (1986)
Self-assembly and thermal phase transition behavior of unsymmetrical bolaamphiphiles having glucose- and amino-hydrophilic headgroups.
N. Kameta (2007)
Peptide-targeted PEG-liposomes in anti-angiogenic therapy.
A. P. Janssen (2003)
Influence of Drug-to-Lipid Ratio on Drug Release Properties and Liposome Integrity in Liposomal Doxorubicin Formulations
M. J. W. Johnston (2008)
pH-sensitive non-phospholipid vesicle and macrophage-like cells: binding, uptake and endocytotic pathway.
L. Di Marzio (2008)
Stability and phase separation in mixed monopolar lipid/bolalipid layers.
G. Longo (2007)
Systemic Delivery of Liposomal Short-Chain Ceramide Limits Solid Tumor Growth in Murine Models of Breast Adenocarcinoma
Thomas C. Stover (2005)
Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification.
H. Yuan (2007)
Multilayer structure of an unsymmetrical monolayer lipid membrane with a 'head-to-tail' interface.
M. Masuda (2001)
Bolaamphiphilic Phosphocholines: Structure and Phase Behavior in Aqueous Media
C. D. Meglio (2000)
Improved oral delivery of paclitaxel following administration in nanoemulsion formulations.
S. Tiwari (2006)
Nanostructured lipid matrices for improved microencapsulation of drugs.
R. Mueller (2002)
Brain uptake of thiamine-coated nanoparticles.
P. Lockman (2003)
Bolaamphiphiles with mannose- and tetraalkylammonium head groups as coatings for nucleic acids and possible reagents for transfections
J. Fuhrhop (1987)
Molecular monolayer rods and tubules made of .alpha.-(L-lysine),.omega.-(amino) bolaamphiphiles
J. Fuhrhop (1993)
Influence of the phospholipid structure on the stability of liposomes in serum.
K. Agarwal (1986)
Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non‐Hodgkin lymphoma
M. Rodriguez (2009)
Pharmacokinetics of Pegylated Liposomal Doxorubicin
A. Gabizon (2003)
Solid lipid nanoparticles (SLN) based on binary mixtures of liquid and solid lipids: a (1)H-NMR study.
V. Jenning (2000)
Biophysical interactions with model lipid membranes: applications in drug discovery and drug delivery.
Chiranjeevi Peetla (2009)
A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt®) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study
S. Phuphanich (2006)
In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
H. L. Wong (2007)
Liposomal targeting of angiogenic vasculature.
R. Schiffelers (2005)
Phototriggering of liposomal drug delivery systems.
P. Shum (2001)
Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer.
E. Kawasaki (2005)
Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
D. Kirpotin (1997)
Complementary molecular shapes and additivity of the packing parameter of lipids.
V. V. Kumar (1991)
Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies.
A. Gabizon (1999)
A growth factor antagonist as a targeting agent for sterically stabilized liposomes in human small cell lung cancer.
J. Moreira (2001)
Liposomal Nanomedicines: An Emerging Field
D. Fenske (2008)
New frontiers in nanotechnology for cancer treatment.
F. Alexis (2008)
Folate-mediated targeting: from diagnostics to drug and gene delivery.
C. P. Leamon (2001)
Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial
GJ Timmers (2000)
Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models.
D. Kirpotin (2006)
Solid Lipid Nanoparticles Enhance the Delivery of the HIV Protease Inhibitor, Atazanavir, by a Human Brain Endothelial Cell Line
N. Chattopadhyay (2008)
Synthesis and aggregation behaviour of symmetric glycosylated bolaamphiphiles in water
A. Polidori (2006)
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
Folate receptor-targeted drugs for cancer and inflammatory diseases.
P. Low (2004)
THE AMPHOTERICIN B LIPID COMPLEX OR ABELCET: ITS BELGIAN CONNECTION, ITS MODE OF ACTION AND SPECIFICITY : A REVIEW
A. Trouet (2002)
Roles of lipid polymorphism in intracellular delivery.
I. M. Hafez (2001)
Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives
Melike Üner (2007)
LIPOSOMES : AN INDUSTRIAL VIEW
D. Lasić (1996)
Highly Thermostable Liposome from 72-Membered Macrocyclic Tetraether Lipid: Importance of 72-Membered Lipid for Archaea to Thrive under Hyperthermal Environments
K. Arakawa (2001)
Cationic vesicles from novel bolaamphiphilic compounds
M. Popov (2010)
Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models
A. Gabizon (2009)
M. Ferrari (2005)
Tumor-Targeted Nanomedicines: Enhanced Antitumor Efficacy In vivo of Doxorubicin-Loaded, Long-Circulating Liposomes Modified with Cancer-Specific Monoclonal Antibody
T. Elbayoumi (2009)
Myocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapy
G. Batist (2002)
Synthesis of novel cationic bolaamphiphiles from vernonia oil and their aggregated structures.
S. Grinberg (2008)
Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.
M. Muthu (2009)
Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line.
L. Serpe (2004)
Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates.
A. Gabizon (2004)
Aqueous self-assembly of unsymmetric Peptide bolaamphiphiles into nanofibers with hydrophilic cores and surfaces.
Randal C. Claussen (2003)
Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release.
T. Andresen (2005)
Lipid nanotubes and microtubes: experimental evidence for unsymmetrical monolayer membrane formation from unsymmetrical bolaamphiphiles.
Mitsutoshi Masuda (2004)
Bolaamphiphilic Single-Chain Bis-Schiff Base Derivatives: Aggregation and Thermal Behavior in Aqueous Solution
X. Wang (2001)
Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases.
G. Haran (1993)
Bioavailability and therapeutic efficacy of HER2 scFv-targeted liposomal doxorubicin in a murine model of HER2-overexpressing breast cancer
Kimberley M Laginha (2008)
Preparation and electrochemical behavior of gramicidin-bipolar lipid monolayer membranes supported on gold electrodes.
J-M Kim (2003)
Liposomes: preparation, characterization, and preservation.
D. Lichtenberg (1988)
Pegylated liposomal doxorubicin HCL (PLD; Caelyx/Doxil): experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancer.
E. Andreopoulou (2007)
Cellular Association and Cytotoxicity of Doxorubicin-Loaded Immunoliposomes Targeted via Fab' Fragments of an Anti-CD74 Antibody
B. Lundberg (2007)
Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis.
R. Pandey (2005)
The potential for nanoparticle-based drug delivery to the brain: overcoming the blood–brain barrier
E. Barbu, (2009)
Cytotoxicity of Solid Lipid Nanoparticles as a Function of the Lipid Matrix and the Surfactant
R. Mueller (2004)
A review of stimuli-responsive nanocarriers for drug and gene delivery.
Srinivas Ganta (2008)
Nanocarrier Technologies: Frontiers of Nanotherapy
M. Mozafari (2006)
Stability and rupture of archaebacterial cell membrane: a model study.
S. Li (2009)
Spontaneously formed monodisperse biomimetic unilamellar vesicles: the effect of charge, dilution, and time.
M. Nieh (2004)
Liposomes containing alkylated methotrexate analogues for phospholipase A(2) mediated tumor targeted drug delivery.
T. Kaasgaard (2009)
Magnetoliposomes: versatile innovative nanocolloids for use in biotechnology and biomedicine.
S. Soenen (2009)
P0 protein mediated targeting of liposomes to melanoma cells with high level of ICAM-1 expression.
M. R. Jaafari (1999)
Receptor-Specific Targeting with Liposomes In Vitro Based on Sterol-PEG1300 Anchors
M. Gantert (2008)
Design of Folate-Linked Liposomal Doxorubicin to its Antitumor Effect in Mice
A. Yamada (2008)
The role of daidzein-loaded sterically stabilized solid lipid nanoparticles in therapy for cardio-cerebrovascular diseases.
Y. Gao (2008)
Solid lipid nanoparticles: production, characterization and applications.
W. Mehnert (2001)
Recent advances with liposomes as pharmaceutical carriers
V. Torchilin (2005)
Oxidation-responsiveness of nanomaterials for targeting inflammatory reactions
V. Khutoryanskiy (2008)
Preclinical Manufacture of Anti‐HER2 Liposome‐Inserting, scFv‐PEG‐Lipid Conjugate. 2. Conjugate Micelle Identity, Purity, Stability, and Potency Analysis
David F. Nellis (2005)
SYNTHESIS AND AGGREGATION OF TWO-HEADED SURFACTANTS BEARING AMINO ACID MOIETIES
S. Franceschi (1999)
Unimolecular micelles and reverse micelles based on hyperbranched polyethers—Comparative study of AB2 + A‐R and A2 + B3 + A‐R type strategies
Animesh Saha (2009)
Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)--effects of formulation parameters on physicochemical stability.
Veerawat Teeranachaideekul (2007)
Folate-mediated targeting of therapeutic and imaging agents to cancers.
J. Reddy (1998)
Asymmetric black membranes formed by one monolayer of bipolar lipids at the air/water interface.
A. Gliozzi (1994)
Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro.
R. Lee (1995)
Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers
P. Midoux (2009)
Design of Photocleavable Lipids and Their Application in Liposomal “Uncorking”.
Binita Chandra (2005)
Design and characterization of a new drug nanocarrier made from solid-liquid lipid mixtures.
M. Garcia-Fuentes (2005)
A phase I study of OSI-211 and cisplatin as intravenous infusions given on days 1, 2 and 3 every 3 weeks in patients with solid cancers.
M. Mackenzie (2004)
A membrane contactor for the preparation of solid lipid nanoparticles
C. Charcosset (2006)
Preparation and characteristics of monostearin nanostructured lipid carriers.
F. Hu (2006)
This paper is referenced by
AN ADVANCED NANOTECHNOLOGY FOR CANCER THERAPY: A REVIEW
S. S. Dudhamal (2015)
Involvement of the lysosomal protein NPC1 in the pathogenesis of Huntington's disease
E. Clark (2017)
Protein Delivery into the Cell Cytosol using Non-Viral Nanocarriers
Yi-Wei Lee (2019)
Production of dynamic lipid bilayers using the reversible thiol-thioester exchange reaction.
D. Konetski (2018)
Liposomal Encapsulation for Systemic Delivery of Propranolol via Transdermal Iontophoresis Improves Bone Microarchitecture in Ovariectomized Rats
Benjamin Teong (2017)
The Critical Role of Mechanism-Based Models for Understanding and Predicting Liposomal Drug Loading, Binding and Release Kinetics
Sweta Modi (2013)
Nanomaterials and Plant Potential: An Overview
A. Husen (2019)
Fabrication of regenerated cellulose nanoparticles by mechanical disintegration of cellulose after dissolution and regeneration from a deep eutectic solvent
J. Sirviö (2019)
Thymoquinone-based nanotechnology for cancer therapy: promises and challenges.
Farah Ballout (2018)
Externally modulated theranostic nanoparticles.
Cordula Urban (2013)
Application of nanoparticles in percutaneous delivery of active ingredients in cosmetic preparations.
Khadijeh Khezri (2018)
Atomistic Molecular Dynamics Simulations of Trioleoylglycerol – Phospholipid Membrane Systems
M. A. Hammad (2020)
Lipogels responsive to near-infrared light for the triggered release of therapeutic agents.
F. Martín-Saavedra (2017)
OF SURFACTANT-FREE , FLUORESCENT POLY ( LACTIC-CO-GLYCOLIC ) ACID NANOPARTICLES TARGETED TO INTERCELLULAR ADHESION MOLECULE-1
Zois Tsinas (2015)
Triggered release of molecules across droplet interface bilayer lipid membranes using photopolymerizable lipids.
S. Punnamaraju (2012)
Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues
B. Kevadiya (2020)
Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: A Review of the Effect of Physicochemical Formulation Factors in the Optimization Process, Different Preparation Technique, Characterization, and Toxicity
G. Poovi (2019)
Nanoassembly of surfactants with interfacial drug-interactive motifs as tailor-designed drug carriers.
X. Gao (2013)
Nanocarriers for anticancer drugs--new trends in nanomedicine.
J. Drbohlavová (2013)
Exosome mimetics: a novel class of drug delivery systems
S. A. Kooijmans (2012)
Opioid-based micro and nanoparticulate formulations: alternative approach on pain management
André São Pedro (2016)
Biocompatible crosslinked β-cyclodextrin nanoparticles as multifunctional carriers for cellular delivery.
S. Datz (2018)
From lab to market: An integrated bioprocess design approach for new‐to‐nature biosurfactants produced by Starmerella bombicola
Lisa Van Renterghem (2018)
Recent advances in porphyrin-based nanocomposites for effective targeted imaging and therapy.
Navid Rabiee (2019)
Liposome-targeted delivery for highly potent drugs
H. Bardania (2017)
Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting.
Mukta Agrawal (2020)
CATIONIC BOLAAMPHIPHILES FOR GENE DELIVERY
Amelia Tan (2014)
Optimization of Nanoemulsion Fabrication Using Microfluidization: Role of Surfactant Concentration on Formation and Stability
Sibel Uluata (2015)
Preclinical studies of N 3O-toluyl-fluorouracil-loaded lipid-based nanosuspensions in h 22-bearing mice
J. Zhang (2014)
Lipid-based nanoparticles as novel drug delivery systems for antimicrobial agents
A. Rassouli (2019)
Effect of DOPE and cholesterol on the protein adsorption onto lipid nanoparticles
G. Caracciolo (2013)
Applications of nanosystems to anticancer drug therapy (Part II. Dendrimers, micelles, lipid-based nanosystems).
M. E. Ruiz (2014)See more